Rani Therapeutics Files 2025 Proxy Statement
Ticker: RANI · Form: DEF 14A · Filed: Apr 16, 2025 · CIK: 1856725
| Field | Detail |
|---|---|
| Company | Rani Therapeutics Holdings, Inc. (RANI) |
| Form Type | DEF 14A |
| Filed Date | Apr 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: RANI
TL;DR
Rani Therapeutics (RANI) proxy filing out for May 28th meeting - vote your shares!
AI Summary
Rani Therapeutics Holdings, Inc. filed its Definitive Proxy Statement (DEF 14A) on April 16, 2025, for its annual meeting on May 28, 2025. The filing concerns the election of directors and other corporate governance matters. The company is based in San Jose, CA, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership and voting matters, allowing them to make informed decisions at the upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a routine annual proxy filing and does not contain new financial or operational disclosures that would inherently increase risk.
Key Numbers
- 20250416 — Filing Date (Date the DEF 14A was filed with the SEC.)
- 20250528 — Meeting Date (Date of the shareholder meeting for which the proxy statement is issued.)
Key Players & Entities
- Rani Therapeutics Holdings, Inc. (company) — Registrant
- 0001140361-25-014078 (filing_id) — Accession Number
- 20250416 (date) — Filing Date
- 20250528 (date) — Meeting Date
- 2051 RINGWOOD AVENUE, SAN JOSE, CA 95131 (address) — Company Address
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the annual meeting on May 28, 2025, including the election of directors and other corporate governance matters.
When was this proxy statement filed with the SEC?
This proxy statement was filed on April 16, 2025.
What is the company's principal business address?
The company's principal business address is 2051 RINGWOOD AVENUE, SAN JOSE, CA 95131.
What is the standard industrial classification for Rani Therapeutics Holdings, Inc.?
The standard industrial classification is PHARMACEUTICAL PREPARATIONS [2834].
What is the SEC file number for Rani Therapeutics Holdings, Inc.?
The SEC file number is 001-40672.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 16, 2025 regarding Rani Therapeutics Holdings, Inc. (RANI).